NCT04336449View on ClinicalTrials.gov

Eptinezumab in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

August 13, 2020

Study Completion Date

August 13, 2020

Conditions
Healthy
Interventions
DRUG

Eptinezumab

Eptinezumab - single intravenous infusion

DRUG

Placebo

Placebo - single intravenous infusion

Trial Locations (1)

Unknown

P-One Clinic, Tokyo

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04336449 - Eptinezumab in Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter